These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11911297

  • 1. Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.
    Nilsson A, Janson ET, Eriksson B, Larsson A.
    Anticancer Res; 2001; 21(6A):4087-90. PubMed ID: 11911297
    [Abstract] [Full Text] [Related]

  • 2. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 3. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Brodin O, Wagenius G.
    Anticancer Res; 1998 Aug; 18(2A):1123-7. PubMed ID: 9615776
    [Abstract] [Full Text] [Related]

  • 4. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP, O'Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC, Harris AL.
    Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222
    [Abstract] [Full Text] [Related]

  • 5. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 6. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, Kohno H, Nagasue N.
    Cancer; 2002 Nov 15; 95(10):2188-95. PubMed ID: 12412173
    [Abstract] [Full Text] [Related]

  • 9. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 10. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L, Andrýs C, Krejsek J, Belada DZ, Zák P, Siroký O, Malý J.
    Vnitr Lek; 2007 Nov 01; 53(11):1171-6. PubMed ID: 18277626
    [Abstract] [Full Text] [Related]

  • 11. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA, Mann L, Cox K, Treadway P, Iversen P, Chen YF, Teicher BA.
    Cancer Chemother Pharmacol; 2003 Apr 01; 51(4):321-7. PubMed ID: 12721760
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E, Skopińska-Rózewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I, Kazoń M.
    Anticancer Res; 2001 Apr 01; 21(6B):4259-63. PubMed ID: 11908679
    [Abstract] [Full Text] [Related]

  • 13. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
    Brivio F, Lissoni P, Rovelli F, Nespoli A, Uggeri F, Fumagalli L, Gardani G.
    Hepatogastroenterology; 2002 Apr 01; 49(44):385-7. PubMed ID: 11995457
    [Abstract] [Full Text] [Related]

  • 14. [Significantly increased concentrations of the angiogenic growth factor bFGF in malignant soft tissue tumors].
    Lehnhardt M, Vogt PM, Wagner D, Steinau HU.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Apr 01; 115(Suppl I):119-23. PubMed ID: 14518225
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J, Jankewicz J, Stepień H.
    Cytobios; 2000 Apr 01; 101(398):151-9. PubMed ID: 10755214
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
    Oliver VK, Patton AM, Desai S, Lorang D, Libutti SK, Kohn EC.
    J Cell Physiol; 2003 Oct 01; 197(1):139-48. PubMed ID: 12942550
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
    Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A.
    Hepatogastroenterology; 2003 Oct 01; 50(50):308-9. PubMed ID: 12749209
    [Abstract] [Full Text] [Related]

  • 18. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST.
    Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr 15; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 20. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP, Li JD, Li MD, Ye XM, Yan WC.
    Ai Zheng; 2002 Feb 15; 21(2):181-5. PubMed ID: 12479072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.